Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight
- 1 July 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 153 (1) , 18-21
- https://doi.org/10.1111/j.1365-2133.2005.06629.x
Abstract
The presence of tumour-infiltrating lymphocytes (TILs) amid the tumour cells in the stroma and overlying epidermis is a constant feature of melanoma, the deadliest skin cancer. These lymphocytes are mostly cytotoxic T cells (CTLs) that can be propagated in vitro by specific cytokines. Also, they can kill melanoma cells. This specific killing can be abrogated by monoclonal antibodies against CD3, CD8, T-cell receptors (TCRs) and against class I human leucocyte antigens (HLAs). This indicates that these CTLs can recognize the melanoma cells through the TCRs, in an HLA class I-restricted manner. Therefore, these cells and their products both are critical players in T cell-induced melanoma regression and are powerful predictors of survival. This review seeks to examine the characteristics, activation and role of TILs and their associated molecules in melanomas.Keywords
This publication has 20 references indexed in Scilit:
- Genetic pathways to melanoma tumorigenesisJournal of Clinical Pathology, 2004
- T cell receptors: affinities, cross-reactivities, and a conformer modelMolecular Immunology, 2004
- p53-related pathways and the molecular pathogenesis of melanomaEuropean Journal Of Cancer Prevention, 2003
- Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: application to melanoma vaccine developmentGene Therapy, 1997
- Immunobiology of Human Melanoma Antigens MART-1 and gp100 and their Use for Immuno-Gene TherapyInternational Reviews of Immunology, 1997
- Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanomaCancer, 1996
- Melanoma Tumor-Infiltrating Lymphocytes Derived from Four Distinct Anatomic Sites Obtained from a Single PatientJournal of Immunotherapy, 1995
- Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon ? secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cellsCancer Immunology, Immunotherapy, 1995
- Lymphocyte-Melanoma Interaction: Role of Surface MoleculesPublished by Springer Nature ,1995
- Isolation and characterization of γδ T lymphocyte cell lines from Sinclair swine peripheral bloodVeterinary Immunology and Immunopathology, 1993